# Endothelial Microparticles as a Biomarker for Diagnosis and Prognosis in Early Sepsis

> **NCT01998139** · — · COMPLETED · sponsor: **Weill Medical College of Cornell University** · enrollment: 137 (actual)

## Conditions studied

- Systemic Inflammatory Response Syndrome

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01998139
- **Lead sponsor:** Weill Medical College of Cornell University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2013-07
- **Primary completion:** 2019-02
- **Final completion:** 2019-02
- **Target enrollment:** 137 (ACTUAL)
- **Last updated:** 2020-07-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01998139

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01998139, "Endothelial Microparticles as a Biomarker for Diagnosis and Prognosis in Early Sepsis". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01998139. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*